Nurse Practitioner · Orchard Park, NY
NPI
1437134947
Since 2005
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6435 Webster Rd
Orchard Park, NY, 14127
Phone (716) 266-6664
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
276 services
Medicare patients, 2024
80
Average age 70
Drug cost, 2024
$1.6M
8,466 prescriptions
Company payments, 2025
$2,873
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles W Burns was code 99214 (office e&m - established), 62 times for 44 patients. In total Charles W Burns billed 276 services in 28 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 62 | 44 | $60.47 | $3,749 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 42 | 42 | $104.41 | $4,385 |
| 99213 Office E&M - Established | Office | 41 | 36 | $38.13 | $1,563 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 40 | 40 | $15.13 | $605 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 12 | 12 | $10.58 | $127 |
By year: 2022 $14K for 288 services; 2023 $22K for 330 services; 2024 $14K for 276 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 15 | 13 | $8.96 | $134 |
Medicare prescription drug claims, 2024
In 2024, the drug Charles W Burns prescribed most often to Medicare patients was Rosuvastatin Calcium, with 518 prescriptions and refills. In total Charles W Burns wrote 8,466 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 518 | 1,503 | 157 | $10K |
| Metoprolol Succinate Generic | 264 | 755 | 78 | $5,323 |
| Levothyroxine Sodium Generic | 251 | 728 | 69 | $4,715 |
| Lisinopril Generic | 248 | 696 | 67 | $2,552 |
| Pantoprazole Sodium Generic | 240 | 662 | 74 | $4,224 |
| Atorvastatin Calcium Generic | 210 | 586 | 62 | $3,869 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 200 | 233 | 83 | $6,894 |
| Valsartan Generic | 172 | 504 | 54 | $4,187 |
| Amlodipine Besylate Generic | 167 | 464 | 55 | $1,645 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 164 | 164 | 50 | $2,244 |
| Omeprazole Generic | 159 | 434 | 43 | $2,924 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 149 | 187 | 28 | $115K |
| Metformin Hcl Er Metformin Hcl | 140 | 397 | 43 | $2,417 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 133 | 192 | 33 | $25K |
| Ibuprofen Generic | 123 | 147 | 42 | $1,334 |
Brand drugs: 1,420 claims; generic drugs: 6,989 claims; opioid claims: 358.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Charles W Burns $2,873 ($2,873 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,080.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $1,080 |
| Lilly USA, LLC LLY | 17 | $250 |
| Abbvie Inc. ABBV | 14 | $232 |
| Boston Scientific Corporation BSX | 2 | $174 |
| Exact Sciences Corporation EXAS | 5 | $143 |
| Pfizer Inc. PFE | 5 | $119 |
| Axsome Therapeutics, Inc. AXSM | 5 | $101 |
| Verona Pharma, Inc. VRNA | 5 | $90.02 |
| Novo Nordisk Inc NVO | 4 | $82.92 |
| GlaxoSmithKline, LLC. GSK | 4 | $78.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.